Majority of Americans don't know the Affordable Care Act's individual mandate was repealed or are unsure; health providers and anti-abuse agencies are collaborating to better care for victims of domestic abuse; preventive care doesn't reduce overall costs, but it does improve quality of life.
A new poll from Kaiser Family Foundation found that the majority of Americans either don’t know that the Affordable Care Act (ACA)’s individual mandate was repealed or are unsure. The Hill reported that only 36% of people surveyed were aware that Congress had repealed the mandate, which requires people to pay a penalty if they don’t have health insurance. Close to half (46%) believed the mandate hasn’t been repealed, while 18% were unsure. Congress’ repeal of the individual mandate takes effect in 2019.
Health providers around the country are working to better identify victims of domestic abuse to get them help, such as counseling. Victims can suffer long-term health issues that translate into higher health costs than people who have not experienced abuse, according to Kaiser Health News. The ACA has helped drive collaboration between providers and anti-abuse agencies since the law requires domestic violence screening and counseling. In California, a women’s center will open a short-term shelter for victims who don’t have a place to go after they are treated in the emergency department.
Providing patients, especially those with chronic diseases, with access to covered preventive care is supposed to reduce overall healthcare spending by ensuring patients get care before they get seriously sick. However, the truth is that there are no data to back up that claim, according to The New York Times blog The Upshot. The reality is that people use care more when the cost for it is reduced. While prevention does not reduce spending, research has found that it improves outcomes, makes people healthier, and improves quality of life—all for a reasonable price.
Elevated Inflammatory Marker Levels Associated With Increased Overactive Bladder Risk
April 15th 2025Systemic immune inflammation index, neutrophil-to-lymphocyte ratio, and systemic inflammation response index levels may offer a noninvasive method to identify individuals at increased risk of developing overactive bladder.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
April 15th 2025Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Read More